Rapid Nexus Nanotech Wound Solutions, Inc. Email Format

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

Rapid Nexus Nanotech Wound Solutions, Inc. is a small clinical-stage medical technology company based in Brea, California, operating in the medical equipment manufacturing space. It has developed Hemastyl, a wound treatment designed specifically for peri-wound care and neuropathy, with the aim of improving healing in wounds associated with nerve damage. Neuropathy, often linked to diabetes, can cause nerve injury in the limbs and create chronic, non-healing wounds that increase the risk of infection and amputation. In April 2026, the company announced supply contracts with the U.S. Department of Veterans Affairs and the Department of Defense and said Hemastyl would begin commercial deployment in May 2026. The product has FDA clearance and has shown closure rates averaging 95.5% across 22 high-risk wounds, including some initially designated for amputation.

Get verified Rapid Nexus Nanotech Wound Solutions, Inc. emails free

Company overview Employee directory